Semaglutide • Novo Nordisk
10-15%
Avg Weight Loss
Weekly
injection
4.5
User Rating
$900
Starting Price
Ozempic (Semaglutide) is a GLP-1 receptor agonist manufactured by Novo Nordisk. It is administered as a weekly injection and is FDA-approved for type 2 diabetes and cardiovascular.
Clinical trials have shown an average weight loss of 10-15% of body weight. The medication works by mimicking the GLP-1 hormone, which helps regulate appetite and blood sugar levels.
Based on clinical trials and user reports. Most side effects decrease over time.
4.5
28,453 reviews
Jennifer M.Verified
Denver, CO
I've tried every diet imaginable and nothing stuck. After 4 months on this medication, I've lost 32 pounds and my relationship with food has completely changed. The first few weeks were rough with nausea, but it subsided. My doctor is thrilled with my progress.
Robert K.Verified
Miami, FL
Lost 25 lbs in 3 months which is amazing. The nausea was pretty bad during the titration phase but manageable with smaller meals. Energy levels are better and my blood sugar is under control. Would recommend but be prepared for an adjustment period.
Maria S.Verified
Phoenix, AZ
As a Type 2 diabetic, this medication has been incredible. A1C went from 8.1 to 5.8 in 6 months. Weight loss of 40+ pounds. I feel like a different person. Insurance covers most of it which helps with the cost.
David L.
Austin, TX
The weight loss is real - down 18 lbs in 2 months. However, the GI side effects have been persistent for me. Still dealing with nausea and have had to adjust my eating schedule significantly. Results are good but the journey is tough.